X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (142) 142
index medicus (121) 121
female (87) 87
male (82) 82
middle aged (79) 79
rheumatology (72) 72
adult (68) 68
vasculitis (65) 65
aged (58) 58
wegeners-granulomatosis (44) 44
abridged index medicus (42) 42
churg-strauss-syndrome (42) 42
polyarteritis-nodosa (38) 38
medicine, general & internal (35) 35
immunology (34) 34
treatment outcome (33) 33
anca-associated vasculitis (32) 32
retrospective studies (32) 32
microscopic polyangiitis (30) 30
term-follow-up (30) 30
immunosuppressive agents - therapeutic use (29) 29
prognosis (28) 28
care and treatment (26) 26
rituximab (26) 26
life sciences (24) 24
disease (22) 22
adolescent (20) 20
antibody-associated vasculitis (20) 20
classification (20) 20
recurrence (20) 20
risk factors (20) 20
antibodies (19) 19
cyclophosphamide (19) 19
diagnosis (19) 19
poor-prognosis factors (19) 19
young adult (19) 19
scleroderma (18) 18
adrenal cortex hormones - therapeutic use (17) 17
antineutrophil cytoplasmic antibodies (17) 17
antineutrophil cytoplasmic autoantibodies (17) 17
aged, 80 and over (16) 16
anca (16) 16
cyclophosphamide - therapeutic use (16) 16
follow-up studies (16) 16
systemic-necrotizing-vasculitides (16) 16
analysis (15) 15
churg-strauss syndrome (15) 15
granulomatosis with polyangiitis (15) 15
biopsy (14) 14
patients (14) 14
allergy and immunology (13) 13
autoantibodies (13) 13
diagnosis, differential (13) 13
internal medicine (13) 13
randomized-trial (13) 13
research (13) 13
scleroderma, systemic - complications (13) 13
therapy (13) 13
drug therapy, combination (12) 12
france - epidemiology (12) 12
prospective studies (12) 12
severity of illness index (12) 12
systemic scleroderma (12) 12
treatment (12) 12
churg-strauss syndrome - diagnosis (11) 11
eosinophilic granulomatosis with polyangiitis (11) 11
human health and pathology (11) 11
involvement (11) 11
medicine & public health (11) 11
remission induction (11) 11
rheumatoid-arthritis (11) 11
glucocorticoids - therapeutic use (10) 10
granulomatosis (10) 10
mortality (10) 10
plasma exchange (10) 10
survival (10) 10
systemic vasculitis (10) 10
time factors (10) 10
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (9) 9
asthma (9) 9
corticosteroids (9) 9
follow-up (9) 9
france (9) 9
glucocorticoids (9) 9
medical research (9) 9
polyangiitis (9) 9
prevalence (9) 9
rheumatology 1990 criteria (9) 9
systemic sclerosis (9) 9
12 cyclophosphamide pulses (8) 8
allergic granulomatosis (8) 8
animals (8) 8
antibodies, antineutrophil cytoplasmic - immunology (8) 8
autoimmune diseases (8) 8
azathioprine - therapeutic use (8) 8
churg-strauss syndrome - drug therapy (8) 8
clinical trials (8) 8
cohort studies (8) 8
granulomatosis with polyangiitis - diagnosis (8) 8
immunosuppressive agents (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue 18, pp. 1693 - 1700
BACKGROUND—The goal of this work was to assess the safety and efficacy of biologics (ie, tumor necrosis factor-α antagonists and tocilizumab) in patients with... 
Treatment outcome | Biological therapy | Vasculitis | Takayasu arteritis | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | vasculitis | COMPETING RISK | biological therapy | REFERRAL CENTER | treatment outcome | DISEASE-ACTIVITY | TOCILIZUMAB | FACTOR THERAPY | TERM-FOLLOW-UP | MALIGNANCIES | PERIPHERAL VASCULAR DISEASE | NECROSIS-FACTOR INHIBITORS | TNF-ALPHA | Blood Sedimentation | Angiography | Humans | Middle Aged | Drug Evaluation | Takayasu Arteritis - diagnostic imaging | Male | Infliximab - therapeutic use | Adalimumab - adverse effects | Young Adult | Infliximab - adverse effects | Takayasu Arteritis - blood | Antirheumatic Agents - adverse effects | Adult | Female | Retrospective Studies | C-Reactive Protein - analysis | Drug Therapy, Combination | Drug Resistance | Antirheumatic Agents - therapeutic use | Antibodies, Monoclonal, Humanized - adverse effects | Takayasu Arteritis - drug therapy | Etanercept - adverse effects | Molecular Targeted Therapy - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Adalimumab - therapeutic use | Prednisone - therapeutic use | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Etanercept - therapeutic use | Care and treatment | Usage | Diagnosis | Takayasu's arteritis | Tumor necrosis factor inhibitors
Journal Article
Arthritis & Rheumatism, ISSN 0004-3591, 01/2013, Volume 65, Issue 1, pp. 270 - 281
Journal Article
Journal Article
Journal Article
Journal of Immunology, ISSN 0022-1767, 04/2014, Volume 192, Issue 7, pp. 3399 - 3408
The relevance of tissue specificity of microvascular endothelial cells (MECs) in the response to inflammatory stimuli and sensitivity to immune cell-mediated... 
WEGENERS-GRANULOMATOSIS | INTERCELLULAR-ADHESION MOLECULE-1 | INFLAMMATORY-BOWEL-DISEASE | SERUM-LEVELS | E-SELECTIN | ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES | KAPPA-B | IMMUNOLOGY | ANCA-ASSOCIATED VASCULITIDES | PHENOTYPIC HETEROGENEITY | T-CELLS | Kidney - blood supply | Humans | Middle Aged | Kidney - immunology | Male | Organ Specificity - immunology | Young Adult | Kidney - metabolism | Lymphocyte Activation - immunology | Flow Cytometry | Granulomatosis with Polyangiitis - immunology | Inflammation Mediators - pharmacology | Dermis - blood supply | Inflammation Mediators - metabolism | Killer Cells, Natural - immunology | Adult | Female | Granulomatosis with Polyangiitis - physiopathology | Lung - metabolism | Microscopic Polyangiitis - immunology | Cytotoxicity, Immunologic - drug effects | Cytokines - immunology | Inflammation Mediators - immunology | Microscopic Polyangiitis - physiopathology | Cell Line | Vascular Cell Adhesion Molecule-1 - immunology | Dermis - metabolism | Cytokines - metabolism | Endothelial Cells - metabolism | Intercellular Adhesion Molecule-1 - immunology | Cells, Cultured | Dermis - immunology | Endothelial Cells - immunology | Intercellular Adhesion Molecule-1 - metabolism | Granulomatosis with Polyangiitis - metabolism | Aged | Microscopic Polyangiitis - metabolism | Killer Cells, Natural - metabolism | Cytotoxicity, Immunologic - immunology | Lung - blood supply | Vascular Cell Adhesion Molecule-1 - metabolism | Cytokines - pharmacology | Lung - immunology | Endothelial Cells - drug effects
Journal Article
Joint Bone Spine, ISSN 1297-319X, 2016, Volume 84, Issue 1, pp. 51 - 57
Abstract Objectives ANCA-associated vasculitis are severe autoimmune pathologies that are characterized by inflammation and necrosis of the small vessels. The... 
Internal Medicine | Rheumatology | Hemopathy | Glomerulopathy | Granulomatous polyangiitis | ANCA-associated vasculitis | Micropolyangiitis | CRESCENTIC GLOMERULONEPHRITIS | METAANALYSIS | CYCLOPHOSPHAMIDE | CONSENSUS CONFERENCE | CLASSIFICATION | RHEUMATOLOGY | B-CELLS | NOMENCLATURE | RITUXIMAB | NON-HODGKINS-LYMPHOMA | Hematologic Neoplasms - therapy | Immunohistochemistry | Age Distribution | Prognosis | Humans | Middle Aged | Male | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy | Glomerulonephritis, Membranous - epidemiology | Hematologic Neoplasms - pathology | Hematologic Neoplasms - epidemiology | Sampling Studies | Antibodies, Antineutrophil Cytoplasmic - immunology | Incidence | Young Adult | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis | Glomerulonephritis, Membranous - immunology | Aged, 80 and over | Female | Retrospective Studies | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - epidemiology | Glomerulonephritis, Membranous - therapy | Severity of Illness Index | Risk Assessment | Comorbidity | Survival Rate | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Glomerulonephritis, Membranous - diagnosis | Sex Distribution | Aged | Biopsy, Needle | Hematologic Neoplasms - immunology | Viral antibodies | Antibodies | Vasculitis | Lymphomas
Journal Article
Journal Article